6Boyle M, Gaffney E F, Thurston A. Paraganglioma of the prostatic urethra. A report of three cases and a review of the literature [J]. Br J Urol, 1996, 77(3) :445-448.
7Pacak K, Eisenhofer G, Carrasquillo J A, et al. 6-[18F] fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma [ J]. Hypertension, 2001, 38(1): 6-8.
8Nieto Palacios A, Martinez Alvarez R, del Barco Mofillo E. Other therapeutic alternatives: radiotherapy and chemotherapy [J]. Aeta Otorrinolaringol Esp, 2009, 60 (Suppl 1): 130-136.
9Edstrom Elder E, Hjelm Skog A L, Hoog A, et al. The management of benign and malignant pheochromocytoma and abdominal paraganglioma [J]. Eur J Surg Oncol, 2003, 29(3) : 278-283.
10John H, Ziegler W H, Hauri D, et al. Pheochromoeytoma: can malignant potential be predicted [J]? Urology, 1999, 53(4):679- 683.
5Park BK, Kim CK, Kwon GY, et al. Re-evaluation of pheo-chromoeytomas on delayed contrast-enhanced CT~ washout enhancement and other imaging features [J]. Eur Radiol, 2007, 17(11) . 2804-2809.
6Meador TL, McLarney JK. CT features of Castleman disease of the abdomen and pelvis]-J~. AJR,2000,175~ 115 118.
7Hideo Matsui,Shunji Ikeuchi,Noboru Onoda,Yutaka Tsutsumi.Malignant Paraganglioma of the Retroperitoneum with Lung Metastases: A 13-year Survivor After Radical Surgery[J]. Asian Journal of Surgery . 2007 (1)
8Emmanuel L. Bravo,Rodrigo Tagle.Pheochromocytoma: State-of-the-Art and Future Prospects[J]. Endocrine Reviews . 2003 (4)
9Sheps S G,Jiang N S,Klee G G.Diagnostic evaluation of pheochromocytoma. Endocrinology and metabolism clinics of North America . 1988
10Amar Laurence,Servais Aude,Gimenez-Roqueplo Anne-Paule,Zinzindohoue Franck,Chatellier Gilles,Plouin Pierre-Fran?ois.Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. The Journal of clinical endocrinology and metabolism . 2005
